NR565/NR565 MID EXAM Advanced Pharmacology 2026/2027
Questions, Answers and Elaborate Rationales(100% verified
and correct answers )
GRADE A+ Chamberlain
1. A patient with type 2 diabetes is prescribed metformin. The nurse practitioner
explains that metformin lowers blood glucose by decreasing hepatic glucose production
and improving insulin sensitivity. How does metformin achieve these effects, and why is
it considered first-line therapy for type 2 diabetes?
A. Stimulates insulin release
B. Decreases hepatic gluconeogenesis and increases peripheral glucose uptake
C. Inhibits SGLT2 in the kidney
D. Blocks GLP-1 receptors
Rationale: Metformin activates AMP-activated protein kinase (AMPK), a cellular energy
sensor that reduces hepatic gluconeogenesis and promotes insulin-mediated glucose uptake
in peripheral tissues like skeletal muscle. This dual mechanism improves glycemic control
without stimulating insulin secretion, thus minimizing the risk of hypoglycemia compared to
sulfonylureas. Its additional benefits include weight neutrality, favorable cardiovascular
effects, and low cost, which is why it is considered first-line therapy in type 2 diabetes.
2. A patient with hypertension is prescribed lisinopril. The nurse practitioner explains
that lisinopril lowers blood pressure by inhibiting the conversion of angiotensin I to
angiotensin II. Which effects result from this mechanism, and why does it help protect
renal function?
A. Beta-1 receptor blockade
B. ACE inhibition, reducing vasoconstriction and aldosterone
C. Calcium channel blockade
D. Diuretic-induced sodium loss
Rationale: Lisinopril inhibits angiotensin-converting enzyme (ACE), reducing levels of
angiotensin II, a potent vasoconstrictor. This leads to systemic vasodilation, decreased
afterload, and reduced aldosterone-mediated sodium and water retention, lowering blood
pressure. Reduced intraglomerular pressure protects renal function, especially in patients
with diabetes or proteinuria. Unlike beta-blockers, calcium channel blockers, or diuretics,
ACE inhibitors directly modulate the renin-angiotensin-aldosterone system (RAAS) and
offer both cardiovascular and renal protective effects.
,3. A patient with chronic heart failure is prescribed carvedilol. The nurse practitioner
explains that carvedilol reduces morbidity and mortality by blocking multiple
adrenergic receptors. Which receptors are involved, and how does this contribute to
improved cardiac function?
A. Alpha-1 and Beta-1/2 receptors
B. Alpha-1 and Beta-1/2 receptors
C. Only Beta-2
D. Only Alpha-1
Rationale: Carvedilol blocks beta-1 receptors, reducing heart rate and myocardial oxygen
demand; beta-2 receptors, lowering arrhythmia risk; and alpha-1 receptors, causing
vasodilation and reduced afterload. This combined blockade improves cardiac output,
reduces left ventricular remodeling, and lowers mortality in heart failure patients. Targeting
only one receptor type would not provide the same comprehensive cardioprotective effect
seen with carvedilol’s multi-receptor action.
4. A patient with chronic pain is prescribed morphine. The nurse practitioner explains
that morphine produces analgesia by activating opioid receptors in the central nervous
system. Which receptor type is primarily responsible, and how does this receptor
reduce pain perception?
A. Delta opioid receptor
B. Kappa opioid receptor
C. Mu opioid receptor
D. Sigma receptor
Rationale: Morphine primarily activates mu opioid receptors in the CNS, resulting in
analgesia, euphoria, and sedation. Activation inhibits presynaptic calcium channels and
enhances postsynaptic potassium conductance, hyperpolarizing neurons and reducing
neurotransmitter release, thus decreasing pain signaling. Delta and kappa receptors contribute
to analgesia but are less potent, while sigma receptors are not involved in opioid-mediated
pain control.
5. A patient with type 2 diabetes is prescribed glipizide. The nurse practitioner explains
that glipizide lowers blood glucose by stimulating insulin release from pancreatic beta
cells. How does this mechanism affect postprandial glucose levels, and what is the risk
associated with this therapy?
A. Stimulates glucagon release
B. Stimulates insulin release from beta cells
C. Enhances hepatic glucose output
D. Blocks insulin receptor
,Rationale: Glipizide binds to sulfonylurea receptors on pancreatic beta cells, closing ATP-
sensitive potassium channels, depolarizing the cell membrane, and triggering insulin release.
This increases insulin during and after meals, reducing postprandial hyperglycemia. The
main risk is hypoglycemia due to excess insulin, especially in elderly patients or those with
irregular meals. Glucagon stimulation, increased hepatic glucose output, or insulin receptor
blockade would worsen glucose control rather than improve it.
6. A patient with chronic asthma is prescribed albuterol. The nurse practitioner
explains that albuterol acts as a bronchodilator by stimulating beta-2 adrenergic
receptors in bronchial smooth muscle. How does this receptor activation lead to
improved airflow?
A. Alpha-1 receptor activation
B. Beta-2 receptor activation
C. Muscarinic receptor inhibition
D. Leukotriene receptor blockade
Rationale: Albuterol activates beta-2 adrenergic receptors, stimulating adenylate cyclase to
increase intracellular cAMP, which relaxes bronchial smooth muscle and leads to
bronchodilation. This rapid effect improves airflow and relieves acute bronchospasm. Alpha-
1 receptors mediate vasoconstriction, muscarinic receptors mediate cholinergic
bronchoconstriction, and leukotriene antagonists like montelukast act via a different
pathway.
7. A patient with epilepsy is prescribed phenytoin. The nurse practitioner explains that
phenytoin stabilizes neuronal membranes by modulating sodium channels. Which
mechanism accounts for seizure suppression, and why is monitoring plasma levels
important?
A. Calcium channel blockade
B. Sodium channel inhibition
C. Potassium channel activation
D. GABA receptor agonism
Rationale: Phenytoin inhibits voltage-gated sodium channels, prolonging their inactive state
and preventing repetitive neuronal firing. This reduces the likelihood of seizure propagation.
Because phenytoin has a narrow therapeutic index, plasma levels must be monitored to
maintain efficacy while avoiding toxicity, which can cause nystagmus, ataxia, or gingival
hyperplasia. Calcium and potassium channel effects or GABA modulation are secondary or
unrelated mechanisms.
8. A patient with depression is prescribed fluoxetine. The nurse practitioner explains
that fluoxetine increases serotonin levels in the synapse. How does serotonin reuptake
, inhibition improve mood, and why might it take several weeks to observe clinical
effects?
A. Blocks dopamine reuptake
B. Inhibits serotonin reuptake
C. Increases GABA release
D. Activates norepinephrine receptors
Rationale: Fluoxetine inhibits the serotonin transporter (SERT), preventing reuptake of
serotonin into presynaptic neurons and increasing synaptic serotonin levels. Over time, this
causes downstream adaptations, including receptor desensitization and neuroplasticity
changes that improve mood. The therapeutic effect may take several weeks despite early
increases in serotonin, as these adaptive changes develop gradually. Dopamine, GABA, and
norepinephrine are not the primary targets of SSRIs.
9. A patient with chronic heart failure is prescribed digoxin. The nurse practitioner
explains that digoxin increases cardiac contractility by inhibiting Na+/K+ ATPase. How
does this effect enhance myocardial performance and control ventricular rate in atrial
fibrillation?
A. Beta-1 receptor stimulation
B. Na+/K+ ATPase inhibition
C. Calcium channel blockade
D. Potassium channel activation
Rationale: Digoxin inhibits Na+/K+ ATPase, increasing intracellular sodium, which reduces
the activity of the sodium-calcium exchanger and results in increased intracellular calcium in
cardiac myocytes. Elevated calcium enhances contractility (positive inotropy). Digoxin also
increases vagal tone, slowing AV nodal conduction, which controls ventricular rate in atrial
fibrillation. Beta-1 stimulation, calcium channel blockade, and potassium channel activation
do not simultaneously account for improved contractility and rate control.
10. A patient with type 2 diabetes is prescribed sitagliptin. The nurse practitioner
explains that sitagliptin enhances incretin activity. Which enzyme is inhibited, and how
does this improve glucose-dependent insulin secretion and glycemic control?
A. GLP-1 receptor
B. DPP-4
C. SGLT2
D. Alpha-glucosidase
Rationale: Sitagliptin inhibits dipeptidyl peptidase-4 (DPP-4), the enzyme that degrades
incretin hormones GLP-1 and GIP. By preventing their breakdown, sitagliptin enhances
glucose-dependent insulin secretion and suppresses glucagon after meals, improving
Questions, Answers and Elaborate Rationales(100% verified
and correct answers )
GRADE A+ Chamberlain
1. A patient with type 2 diabetes is prescribed metformin. The nurse practitioner
explains that metformin lowers blood glucose by decreasing hepatic glucose production
and improving insulin sensitivity. How does metformin achieve these effects, and why is
it considered first-line therapy for type 2 diabetes?
A. Stimulates insulin release
B. Decreases hepatic gluconeogenesis and increases peripheral glucose uptake
C. Inhibits SGLT2 in the kidney
D. Blocks GLP-1 receptors
Rationale: Metformin activates AMP-activated protein kinase (AMPK), a cellular energy
sensor that reduces hepatic gluconeogenesis and promotes insulin-mediated glucose uptake
in peripheral tissues like skeletal muscle. This dual mechanism improves glycemic control
without stimulating insulin secretion, thus minimizing the risk of hypoglycemia compared to
sulfonylureas. Its additional benefits include weight neutrality, favorable cardiovascular
effects, and low cost, which is why it is considered first-line therapy in type 2 diabetes.
2. A patient with hypertension is prescribed lisinopril. The nurse practitioner explains
that lisinopril lowers blood pressure by inhibiting the conversion of angiotensin I to
angiotensin II. Which effects result from this mechanism, and why does it help protect
renal function?
A. Beta-1 receptor blockade
B. ACE inhibition, reducing vasoconstriction and aldosterone
C. Calcium channel blockade
D. Diuretic-induced sodium loss
Rationale: Lisinopril inhibits angiotensin-converting enzyme (ACE), reducing levels of
angiotensin II, a potent vasoconstrictor. This leads to systemic vasodilation, decreased
afterload, and reduced aldosterone-mediated sodium and water retention, lowering blood
pressure. Reduced intraglomerular pressure protects renal function, especially in patients
with diabetes or proteinuria. Unlike beta-blockers, calcium channel blockers, or diuretics,
ACE inhibitors directly modulate the renin-angiotensin-aldosterone system (RAAS) and
offer both cardiovascular and renal protective effects.
,3. A patient with chronic heart failure is prescribed carvedilol. The nurse practitioner
explains that carvedilol reduces morbidity and mortality by blocking multiple
adrenergic receptors. Which receptors are involved, and how does this contribute to
improved cardiac function?
A. Alpha-1 and Beta-1/2 receptors
B. Alpha-1 and Beta-1/2 receptors
C. Only Beta-2
D. Only Alpha-1
Rationale: Carvedilol blocks beta-1 receptors, reducing heart rate and myocardial oxygen
demand; beta-2 receptors, lowering arrhythmia risk; and alpha-1 receptors, causing
vasodilation and reduced afterload. This combined blockade improves cardiac output,
reduces left ventricular remodeling, and lowers mortality in heart failure patients. Targeting
only one receptor type would not provide the same comprehensive cardioprotective effect
seen with carvedilol’s multi-receptor action.
4. A patient with chronic pain is prescribed morphine. The nurse practitioner explains
that morphine produces analgesia by activating opioid receptors in the central nervous
system. Which receptor type is primarily responsible, and how does this receptor
reduce pain perception?
A. Delta opioid receptor
B. Kappa opioid receptor
C. Mu opioid receptor
D. Sigma receptor
Rationale: Morphine primarily activates mu opioid receptors in the CNS, resulting in
analgesia, euphoria, and sedation. Activation inhibits presynaptic calcium channels and
enhances postsynaptic potassium conductance, hyperpolarizing neurons and reducing
neurotransmitter release, thus decreasing pain signaling. Delta and kappa receptors contribute
to analgesia but are less potent, while sigma receptors are not involved in opioid-mediated
pain control.
5. A patient with type 2 diabetes is prescribed glipizide. The nurse practitioner explains
that glipizide lowers blood glucose by stimulating insulin release from pancreatic beta
cells. How does this mechanism affect postprandial glucose levels, and what is the risk
associated with this therapy?
A. Stimulates glucagon release
B. Stimulates insulin release from beta cells
C. Enhances hepatic glucose output
D. Blocks insulin receptor
,Rationale: Glipizide binds to sulfonylurea receptors on pancreatic beta cells, closing ATP-
sensitive potassium channels, depolarizing the cell membrane, and triggering insulin release.
This increases insulin during and after meals, reducing postprandial hyperglycemia. The
main risk is hypoglycemia due to excess insulin, especially in elderly patients or those with
irregular meals. Glucagon stimulation, increased hepatic glucose output, or insulin receptor
blockade would worsen glucose control rather than improve it.
6. A patient with chronic asthma is prescribed albuterol. The nurse practitioner
explains that albuterol acts as a bronchodilator by stimulating beta-2 adrenergic
receptors in bronchial smooth muscle. How does this receptor activation lead to
improved airflow?
A. Alpha-1 receptor activation
B. Beta-2 receptor activation
C. Muscarinic receptor inhibition
D. Leukotriene receptor blockade
Rationale: Albuterol activates beta-2 adrenergic receptors, stimulating adenylate cyclase to
increase intracellular cAMP, which relaxes bronchial smooth muscle and leads to
bronchodilation. This rapid effect improves airflow and relieves acute bronchospasm. Alpha-
1 receptors mediate vasoconstriction, muscarinic receptors mediate cholinergic
bronchoconstriction, and leukotriene antagonists like montelukast act via a different
pathway.
7. A patient with epilepsy is prescribed phenytoin. The nurse practitioner explains that
phenytoin stabilizes neuronal membranes by modulating sodium channels. Which
mechanism accounts for seizure suppression, and why is monitoring plasma levels
important?
A. Calcium channel blockade
B. Sodium channel inhibition
C. Potassium channel activation
D. GABA receptor agonism
Rationale: Phenytoin inhibits voltage-gated sodium channels, prolonging their inactive state
and preventing repetitive neuronal firing. This reduces the likelihood of seizure propagation.
Because phenytoin has a narrow therapeutic index, plasma levels must be monitored to
maintain efficacy while avoiding toxicity, which can cause nystagmus, ataxia, or gingival
hyperplasia. Calcium and potassium channel effects or GABA modulation are secondary or
unrelated mechanisms.
8. A patient with depression is prescribed fluoxetine. The nurse practitioner explains
that fluoxetine increases serotonin levels in the synapse. How does serotonin reuptake
, inhibition improve mood, and why might it take several weeks to observe clinical
effects?
A. Blocks dopamine reuptake
B. Inhibits serotonin reuptake
C. Increases GABA release
D. Activates norepinephrine receptors
Rationale: Fluoxetine inhibits the serotonin transporter (SERT), preventing reuptake of
serotonin into presynaptic neurons and increasing synaptic serotonin levels. Over time, this
causes downstream adaptations, including receptor desensitization and neuroplasticity
changes that improve mood. The therapeutic effect may take several weeks despite early
increases in serotonin, as these adaptive changes develop gradually. Dopamine, GABA, and
norepinephrine are not the primary targets of SSRIs.
9. A patient with chronic heart failure is prescribed digoxin. The nurse practitioner
explains that digoxin increases cardiac contractility by inhibiting Na+/K+ ATPase. How
does this effect enhance myocardial performance and control ventricular rate in atrial
fibrillation?
A. Beta-1 receptor stimulation
B. Na+/K+ ATPase inhibition
C. Calcium channel blockade
D. Potassium channel activation
Rationale: Digoxin inhibits Na+/K+ ATPase, increasing intracellular sodium, which reduces
the activity of the sodium-calcium exchanger and results in increased intracellular calcium in
cardiac myocytes. Elevated calcium enhances contractility (positive inotropy). Digoxin also
increases vagal tone, slowing AV nodal conduction, which controls ventricular rate in atrial
fibrillation. Beta-1 stimulation, calcium channel blockade, and potassium channel activation
do not simultaneously account for improved contractility and rate control.
10. A patient with type 2 diabetes is prescribed sitagliptin. The nurse practitioner
explains that sitagliptin enhances incretin activity. Which enzyme is inhibited, and how
does this improve glucose-dependent insulin secretion and glycemic control?
A. GLP-1 receptor
B. DPP-4
C. SGLT2
D. Alpha-glucosidase
Rationale: Sitagliptin inhibits dipeptidyl peptidase-4 (DPP-4), the enzyme that degrades
incretin hormones GLP-1 and GIP. By preventing their breakdown, sitagliptin enhances
glucose-dependent insulin secretion and suppresses glucagon after meals, improving
